Trial intelligence / Profile preview

SUMMIT: MACI vs Microfracture for Knee Cartilage Defects

NCT00719576Phase 3Completed

Sponsor
Vericel
Start
Jul 2008
Primary completion
Mar 2012
Modality
Cell Therapies
Countries
7
01

Overview

A Phase 3 trial of autologous cultured chondrocytes on porcine collagen membrane in Articular cartilage defect, sponsored by Vericel. Started Jul 2008; status: completed.

02

Drugs

autologous cultured chondrocytes on porcine collagen membrane
03

Conditions

Articular cartilage defect

Beyond the preview

Go deeper on NCT00719576.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00719576.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call